ME/NaPhos/MB/Hyo1 and Siltuximab Intravenous
Determining the interaction of ME/NaPhos/MB/Hyo1 and Siltuximab Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: hyoscyamine / methenamine / methylene blue / sodium biphosphate
Brand name: Urogesic-Blue, UTA, Uro-BLUE, Urolet MB, Indiomin MB, ME/NaPhos/MB/Hyo1, UTA
Synonyms: Hyoscyamine, methenamine, methylene blue, and sodium biphosphate, Methenamine, Methylene Blue, and Sodium Phosphate Monobasic
Generic Name: siltuximab
Brand name: Sylvant
Synonyms: Siltuximab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- ME/NaPhos/MB/Hyo1-Silvadene
- ME/NaPhos/MB/Hyo1-Silvadene Topical
- ME/NaPhos/MB/Hyo1-SilvaSorb
- ME/NaPhos/MB/Hyo1-Silver
- ME/NaPhos/MB/Hyo1-Silver Nitrate
- ME/NaPhos/MB/Hyo1-Silver Nitrate Applicators
- Siltuximab Intravenous-Measles and rubella virus vaccine live Intramuscular, Injection
- Siltuximab Intravenous-Measles virus vaccine, live Subcutaneous
- Siltuximab Intravenous-Measles, mumps, and rubella (MMR) vaccine
- Siltuximab Intravenous-Measles, Mumps, and Rubella Vaccine
- Siltuximab Intravenous-Measles, Mumps, and Rubella Virus Vaccine
- Siltuximab Intravenous-Measles, mumps, and rubella virus vaccine live Subcutaneous, Intramuscular